Items where Subject is "lorlatinib"
![[up]](/style/images/multi_up.png)
Up a level- CSHL Subject List (1)
- diseases & disorders (1)
- cancer (1)
- drugs and therapies (1)
- lorlatinib (1)
- drugs and therapies (1)
- cancer (1)
- diseases & disorders (1)
Group by: Authors | Item Type
Jump to: Paper
Number of items at this level: 1.
Paper
Nielsen, Sebastian R, Strøbech, Jan E, Horton, Edward R, Jackstadt, Rene, Laitala, Anu, Bravo, Marina C, Maltese, Giorgia, Jensen, Adina RD, Reuten, Raphael, Rafaeva, Maria, Karim, Saadia A, Hwang, Chang-Il, Arnes, Luis, Tuveson, David A, Sansom, Owen J, Morton, Jennifer P, Erler, Janine T (June 2021) Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Nature Communications, 12 (1). p. 3414. ISSN 2041-1723